659MO Avelumab (A) as the basis of neoadjuvant chemotherapy (NAC) regimen in platinum eligible and ineligible patients (pts) with non-metastatic muscle invasive bladder cancer (NM-MIBC).

Authors :: Martinez Chanza, N.
Carnot, A.
Barthelemy, P.
Casert, V.
Sautois, B.
Van den Brande, J.
Vanhaudenarde, V.
Staudacher, L.
Seront, E.
Culine, S.
Gizzi, M.
Gil, T.
Paesmans, M.
Kotecki, N.
Ignatiadis, M.
Albisinni, S.
Fantoni, J.C.
Tricard, T.
Roumeguere, T.
Awada, A.H.
Source :: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS683-S683. 1p.
Publication Year :: 2021

Subjects :: *CANCER invasiveness
*NEOADJUVANT chemotherapy
*BLADDER cancer
*PLATINUM
*UROTHELIUM

Full Text Access

Tools